![University of Toronto logo](https://facit.ca/wp-content/uploads/2021/11/University-of-Toronto.png)
University of Toronto (Dr. R. Laposa)
pharmtox.utoronto.ca
Innovation Type:
Therapeutics
Cancer Type:
Multiple
Funding Stage:
Proof of Concept
Fund:
Prospects
Development of small-molecule inhibitors of mitochondrial RNA polymerase (POLRMT) as an anticancer strategy